KRT19 and non-small cell lung carcinoma: Therefore, it is not possible to establish whether or not the detection of serum cytokeratin 19 fragment (sequences 311–335 and 346–367) could be considered as better or equivalent to prognostic determinants of NSCLC when compared with the other new markers.